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Objective To determine whether children with attention deficit hyperactivity disorder (ADHD) and mild intellectual
disability (ID) are a clinically distinct ADHD subgroup.
Study design This was a cross-sectional study comparing clinical characteristics (ADHD subtypes, total number
of symptoms, and rates of common comorbidities) between children with ADHD and mild ID and those with ADHD
and IQ test scores >70, and also between children with ADHD and ID and a general population sample of children
with ID alone. The sample comprised a clinical sample of children with ADHDwith ID (n = 97) and without ID (n = 874)
and a general population sample of children with ID and without ADHD (n = 58).
Results After correcting for multiple statistical tests, no differences were found between the 2 ADHD groups on
any measure except the presence of conduct disorder (CD) symptoms and diagnoses. Children with ADHD and
ID had higher rates of both (OR, 2.38; 95% CI, 1.71-3.32 and OR, 2.69; 95% CI, 1.69-4.28, respectively). Further-
more, children with ADHD and ID had significantly higher rates of oppositional defiant disorder (OR, 5.54; 95% CI,
2.86-10.75) and CD (OR, 13.66; 95% CI, 3.25-57.42) symptoms and a higher incidence of oppositional defiant dis-
order diagnoses (OR, 30.99; 95% CI, 6.38-150.39) compared with children with ID without ADHD.
Conclusion Children with ADHD andmild ID appear to be clinically typical of children with ADHD except for more
conduct problems. This finding has implications for clinicians treating these children in terms of acknowledging
the presence and impact of ADHD symptoms above and beyond ID and dealing with a comorbid CD. (J Pediatr
2013;163:890-5).
A
ttention deficit hyperactivity disorder (ADHD) is a disabling condition, affecting 1.4%-6% of children.1 Little is known
of the clinical presentation and etiology of ADHD in children with intellectual disability (ID), because those with lower
cognitive ability (IQ scores <70) are often excluded from studies of ADHD,2 despite evidence that ADHD is more com-
mon in children with ID, and that the risk increases with increasing severity of ID.3
It has been suggested that ADHD does not occur in children with ID, and that any inappropriate behavior in children with ID
is secondary to “mental impairment.”4 That view is not supported by current evidence, however. Studies have shown that
ADHD occurs more commonly in these children but may be underdiagnosed owing to such issues as “diagnostic overshadow-
ing,” the tendency of clinicians to overlook additional psychiatric diagnoses after a diagnosis of ID is made, or “masking,” in
which the clinical characteristics of a mental disorder are masked by a cognitive, language, or speech deficit.5
A population-based study estimating the prevalence of psychiatric diagnoses in children with ID identified hyperkinetic dis-
order as the most common psychiatric disorder.6 Studies of children withmild and borderline ID have identified ADHD in 8%-
39% of cases.7-9 A crucial clinical issue is whether or not the clinical pattern of comorbidity in this group is the same as that seen
in children with ADHD but without ID. This is important in determining the level and type of services and clinical care required
for this subgroup.
In the present study, we compared the rates of comorbid problems and ADHD symptom levels in 2 groups of childrenFrom the 1Ty Bryn Unit, St Cadocs Hospital, Newport,
United Kingdom; and 2Child and Adolescent Psychiatrywith ADHD, 1 group with ID (ADHD + ID group) and the other group without
ID (ADHD-only group). Consistent with previous studies of ADHD, we defined
ID is an IQ test score <70. We hypothesized that the ADHD profiles in the 2
groups (ADHD+ ID [IQ <70] vs ADHD-only [IQ$70]) would be highly similarSection, Institute of Psychological Medicine and Clinical
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Vol. 163, No. 3  September 2013in terms of symptoms, rates of subtypes, and patterns of co-
morbid problems (ie, oppositional behaviors, conduct disor-
der [CD], anxiety, and depression).
Methods
Participants were recruited from more than 30 child and
adolescent mental health services or community pediatric
outpatient clinics in Wales, England, and Scotland for a ge-
netic study of ADHD. Given this study’s focus on evaluat-
ing for the presence of nonsyndromal ID in children with
ADHD, International Statistical Classification of Diseases
and Related Health Problems, 10th revision10 and Diagnostic
and Statistical Manual of Mental Disorders, 4th edition
(DSM-IV)11 exclusion criteria were used. Children with
a known diagnosis of schizophrenia, autism spectrum disor-
der (ASD), bipolar disorder, Tourette syndrome, epilepsy,
brain damage, or any other neurologic or genetic disorder
were excluded. Information on these conditions was derived
from a questionnaire completed by the referring clinician,
diagnostic interview information obtained from parents,
and quality control of genetic data performed as part of
the genetic study. Children with IQ <50 were also excluded,
because the study focused on mild ID, and the assessment
measures have not yet been validated in individuals with se-
vere ID.
A total of 971 children met the inclusion criteria and had
sufficient data for analysis. All of these children met the
DSM-IV11 or Diagnostic and Statistical Manual of Mental
Disorders, 3rd edition revised (DSM-III-R)12 criteria for a di-
agnosis of ADHD, which was confirmed through research
diagnostic interviews.13 The children ranged in age from 5
to 17 years (mean age, 10.1  2.8 years), and included
148 females (15.2%). The study received ethical approval
from the North West England and Wales Multicentre Re-
search Ethics Committees. For all subjects, written informed
consent was obtained from parents and assent/consent from
children.
Cognitive ability was assessed using the Wechsler Intelli-
gence Scale for Children versions III (n = 381) and IV (n =
590)14,15 to obtain an estimate of full-scale IQ (using all re-
quired subtests). Two versions of this assessment tool were
used because version IV was released during the study period.
The assessment was performed by trained psychologists. In
children who had recently undergone IQ assessment in
school, that score was used to determine ID status. In accor-
dance with International Statistical Classification of Diseases
and Related Health Problems, 10th revision and DSM-IV cri-
teria, children with an IQ score of 50-69 were considered to
have mild mental retardation/ID and classified in the
ADHD+ ID group. Children with an IQ score$70 were clas-
sified in the ADHD-only group.
ADHD symptoms, impairment, and diagnoses were con-
firmed using the Child and Adolescent Psychiatry Assessment
(CAPA),13 a research diagnostic interview with parents.
Interviews were performed by trained psychologists super-
vised weekly by a child psychiatrist. Interrater reliability forADHD was perfect (k = 1.0). Information on ADHD symp-
toms and school impairments was obtained using the Child
ADHD Teacher Telephone Interview,16 the DuPaul teacher
rating scale,17 or the Conners teacher rating scale.18 A diag-
nosis of ADHD required that the child have symptoms meet-
ing DSM-IV or DSM-III-R criteria, substantial impairment
from symptoms at home, and pervasive symptoms and im-
pairment in the school setting.
The CAPA was also used to assess current symptoms, im-
pairment, and DSM-IV diagnoses of comorbid oppositional
defiant disorder (ODD), CD, anxiety disorders (ie, general-
ized anxiety disorder, social anxiety, and separation anxiety),
depression, and mania. Comorbid symptoms were also as-
sessed using the child version of the CAPA19 for children
aged $12 years. Comorbid anxiety or depression symptoms
were endorsed if reported by the parent or child. Owing to
the scarcity of anxiety and depression diagnoses in the sam-
ple, only symptoms of these disorders could be analyzed. In-
terrater reliability for parent-rated CD symptoms was very
good (intraclass correlation, 0.98).
Avon Longitudinal Study of Parents and Children
To compare clinical variables found to be associated in the
primary analysis in the ADHD + ID and ADHD-only
groups, we turned to the Avon Longitudinal Study of Par-
ents and Children (ALSPAC), a large, well-characterized
longitudinal dataset. Details of the study methodology are
available elsewhere.20 Ethical approval for all aspects of
the study was obtained from the ALSPAC Law and Ethics
Committee and the local Research Ethics Committees. Par-
ents provided written consent and the children provided as-
sent at each assessment. IQ had been assessed at age 8 years
using the Wechsler Intelligence Scale for Children version
III.14 Children who scored between 50 and 69 on the IQ
test and had no diagnosis of ADHD or ASD were included
in our analysis. A total of 74 children (1.2% of the ALSPAC
sample with complete data on these measures) met these
criteria. Data on ADHD, ASD, ODD, and CD symptoms
and diagnoses were collected from participants at age 128
months, using the parent and teacher Development and
Well-Being Assessment.21 Complete clinical data were avail-
able for 58 children, who constituted the ID-only group.
These children were 10-11 years old at the time of clinical
assessment (mean, 10.8  0.1 years), and 27 were female
(46.6%).
Statistical Analyses
The ADHD clinical sample was divided into those with ID
(ADHD + ID; n = 97) and those without ID (ADHD-only;
n = 874). The 2 groups were compared on each of the clinical
factors identified. All descriptive statistics are presented as
raw scores for ease of interpretation. Where a variable was
nonnormally distributed, the scores were naturally logarith-
mically transformed, and analyses were run on transformed
scores.
Clinical predictor variables were used to predict binary
outcomes (ADHD + ID or ADHD-only) using regression891
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assessment as a covariate. Sex was not included as a covar-
iate, because it was not associated with the presence or ab-
sence of ID. Clinical variables were assessed both
categorically and continuously, whenever relevant. All
analyses were performed using SPSS version 16 (IBM, Ar-
monk, New York). To take into account multiple testing,
Bonferroni correction for the number of variables tested
was used, a was set at P = .003 (0.05/15) for the 15 tests
performed.
Based on our results, a hypothesis-driven comparison of
the ADHD + ID and ID-only samples was performed for
rates of diagnoses and symptom counts for ODD and CD, ad-
justed for the covariates age, sex, and IQ. CD items available
in both datasets were summed and used to generate the CD
diagnoses (lying, fighting, breaking curfew, stealing, truancy,
running away from home, and bullying).Results
Sample Description: Clinical ADHD Sample
At the time of assessment, 74.3% of the children (n = 721)
met the criteria for DSM-IV ADHD Combined type, 6.0%
(n = 58) met the criteria for DSM-IV ADHD Inattentive
type, 9.6% (n = 93) met the criteria for DSM-IV ADHD
Hyperactive-Impulsive type, and the remaining 10.2%
(n = 99) met the criteria for DSM-III-R ADHD. The rates
of comorbid disorders were 45.2% (n = 435) for DSM-IV
ODD, 17.6% (n = 171) for DSM-IV CD, 6.1% (n = 59)
for any anxiety disorder, and 1.1% (n = 11) for any de-
pressive disorder. The mean IQ test scores were 61.8 
5.4 for the ADHD + ID group and 87.8  11.4 for the
ADHD-only group; the range of scores was 50-69 for the
ADHD + ID group and 70-139 for the ADHD-only group.
The scores were normally distributed for the sample as
a whole.Table I. Clinical features of the ADHD + ID and ADHD-onl
Variable
ADHD + ID (n = 97)
n (%) Mean (SD)
Age, y 11.4 (3.0)
Male sex 84 (86.6)
DSM-IV Combined ADHD diagnosis 79 (82.3)
DSM-IV Inattentive ADHD diagnosis 5 (5.2)
DSM-IV Hyperactive-Impulsive ADHD diagnosis 6 (6.2)
DSM-III-R ADHD diagnosis only 5 (5.2)
DSM-IV ODD diagnosis 36 (37.5)
DSM-IV CD diagnosis 35 (36.1)
ADHD symptoms: inattentive 7.5 (1.5)
ADHD symptoms: hyperactive-impulsive 7.8 (1.4)
ADHD symptoms: total 15.4 (2.1)
DSM-IV ODD symptom count 4.1 (2.3)
DSM-IV CD symptom count 2.1 (2.2)
DSM-IV anxiety symptoms 1.2 (2.0)
DSM-IV depression symptoms 1.8 (1.8)
*All clinical analyses were adjusted for the covariate child’s age.
†Critical P value corrected for multiple testing: P < .003.
zTransformed.
892Sample Description: ID-Only ALSPAC Sample
The mean IQ score of the ID-only group was 64.8  4.5. At
the 128-month assessment, 2 of the children in the ID-only
group met the criteria for DSM-IV ODD (3.4%), and none
met the criteria for DSM-IV CD.
Analysis of Clinical Features in Children with ADHD
The ADHD + ID group was older than the ADHD-only
group, but the 2 groups did not differ in terms of sex distri-
bution. Table I presents the descriptive statistics and results
of regression analyses with age included as a covariate.
Although a trend for the ADHD + ID group to be more
likely to have the DSM-IV Combined ADHD subtype was
seen, this result did not withstand correction for multiple
testing. Otherwise, the 2 groups of children were similar in
terms of ADHD subtypes and Inattentive, Hyperactive-
Impulsive, and total ADHD symptoms. The 2 groups also
had similar rates of ODD diagnoses and of anxiety and
depression symptoms. There was a trend for children with
ADHD + ID to have on more ODD symptoms on average.
The ADHD + ID group had more symptoms of CD and
were more likely to have a diagnosis of CD; these
associations remained after multiple testing was taken into
consideration.
Analysis of Clinical Features in Children
with ID-Only
Results of the comparison of ADHD + ID and ID-only
groups (clinical sample vs population sample) are pre-
sented in Table II. The 2 groups differed significantly in
terms of sex (more boys in the ADHD + ID group), but
not in age at assessment. Although the range of IQ scores
was similar in the 2 groups, the ADHD + ID group had
significantly lower scores (OR, 0.88; 95% CI, 0.82-0.95;
P = .001). After adjusting for sex, age, and IQ score, the
children in the ADHD + ID group were significantly
more likely to have a diagnosis of ODD, and hady groups
ADHD only (n = 874) Statistics*
n (%) Mean (SD) OR 95% CI P†
10.0 (2.7) 1.19 1.11-1.28 4.6E-06
739 (84.6) 0.85 0.46-1.56 .60
631 (72.6) 1.96 1.12-3.40 .02
51 (5.8) 0.62 0.23-1.62 .32
87 (10.0) 0.59 0.25-1.41 .23
89 (10.2) 0.49 0.19-1.26 .14
399 (46.1) 0.74 0.48-1.14 .17
136 (15.6) 2.69 1.69-4.28 2.8E-05
7.3 (1.7) 1.25 0.75-2.09 .39z
7.8 (1.5) 1.38 0.79-2.40 .25z
15.1 (2.4) 1.08 0.98-1.18 .12
3.8 (2.4) 1.09 0.99-1.19 .08
1.0 (1.5) 2.38 1.71-3.32 2.5E-07z
1.1 (1.9) 1.21 0.86-1.70 .28z
1.3 (1.3) 1.26 0.84-1.89 .26z
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Table II. Clinical features of children with ADHD + ID (clinical sample) and those with ID only (ALSPAC sample)
Variables
ADHD + ID (n = 97) ID-only (n = 58) Statistics
n (%) Mean (SD) n (%) Mean (SD) OR 95% CI P
Age, y 11.4 (3.0) 10.8 (0.1) 1.10 0.96-1.27 .16
Male sex 84 (86.6) 31 (53.4) 0.18 0.08-0.39 1.4E-05
ODD symptom count 4.1 (2.3) 0.2 (0.7) 5.54 2.86-10.75 4.0E-07*
CD symptom count (out of 7) 1.2 (1.4) 0.0 (0.3) 13.66 3.25-57.42 3.6E-04*
ODD diagnosis 47 (49.0) 2 (3.4) 30.99 6.38-150.39 2.0E-05*
CD diagnosis 16 (16.7) 0 (0.0) NA NA NA†
NA, not applicable.
*All clinical analyses adjusted for the covariates child’s age at time of assessment, sex, and IQ.
†Because there were no CD diagnoses in the ID-only group, statistical calculation was not applicable.
September 2013 ORIGINAL ARTICLESsignificantly more symptoms of ODD and CD. Statistical
assessment of the between-group difference in the rate of
CD diagnoses was not possible, given the rate of 0 in the
ID-only group.
Discussion
In our clinical sample of children with ADHD, those with and
without mild ID (IQ score 50-69) exhibited similar patterns
of ADHD subtypes, total number of ADHD symptoms, and
comorbidity with ODD, anxiety, and depression. The chil-
dren in the ADHD + ID group did have higher rates of CD
symptoms and diagnoses, however. To explore these results
further and test whether these differences were related to
an increase in behavioral problems in children with ID in
general, we compared our ADHD + ID group with a popula-
tion-based sample of children with ID but without ADHD.
We found significantly higher rates of ODD diagnoses and
ODD and CD symptoms in the ADHD + ID group, suggest-
ing that the combination of ADHD and ID results in in-
creases in the rates of comorbid CD and ODD beyond the
rates of these disorders in individuals with ID only or
ADHD only. The mean IQ score was lower in the ADHD +
ID group compared with the ID-only group. This difference
in IQ may be related to selective attrition in the ALSPAC
sample,22 clinical ascertainment effects, or the effects of
ADHD on IQ test performance. Regardless, when we
matched the groups on IQ scores by selecting a subsample
of children with ADHD + ID (n = 58, to match the number
of children in the ID-only group), we obtained the same pat-
tern of results (Table III; available at www.jpeds.com).
ADHD is one of the most common forms of psychopa-
thology in children with ID.7 Generally, children with ID
are neglected in the medical field, perhaps in part because
of their poor ability to communicate and social disadvan-
tages.2 They are frequently excluded from clinical, etiologic,
and treatment studies,2 and thus few studies to date have
examined the clinical presentation, etiology, patterns of ser-
vice use, and treatment of ADHD in children with ID.
Moreover, there are few standardized norms or guidelines
in the classification systems for identifying “normal” or
“usual” amounts of inattention, overactivity and impulsiv-
ity in persons with ID.Intellectual Disability in Children with Attention Deficit HyperactivStudies with clinic-referred children and community and
population samples have shown consistently higher rates of
ADHD in children with ID and higher rates of ID in children
with ADHD.23-25 There has been less work on whether the
clinical features and levels of ADHD symptomatology differ
between children with ID and those without ID. One study
found equivalent levels of ADHD symptoms in preschool-
age children with ADHD and normal IQ and those with
ADHD and ID.26 A population study assessed overactivity,
inattention, and impulsivity symptoms using the Strengths
and Difficulties Questionnaire in children with IQ <70 and
those with IQ $70 and found no differences between the 2
groups.24 A recent longitudinal study compared children
with ADHD with IQ <85 (indicating ID or borderline IQ)
and those with IQ $85 and found similar inattentive and
hyperactive-impulsive ADHD symptom trajectories over
a 3-year period.27 An important difference noted in that sam-
ple was that the children with lower IQ tended to meet the
diagnostic criteria for ADHD at an earlier age and to have
more diagnostic stability than the children with higher IQ,
indicating a more severely impairing form of ADHD. A study
that addressed this question from the other direction found
that although the children with developmental delay (IQ
<85) had a higher rate of ADHD than the typically develop-
ing children (IQ $85), the pattern of ADHD subtypes and
levels of inattentive and hyperactive-impulsive symptoms
were similar in the 2 groups.9
The few studies examining whether rates of comorbid psy-
chiatric disorders in ADHD differ in children with and with-
out ID have shown mixed results. Some studies have found
higher rates of comorbid impairments in social skills, con-
duct problems, aggression, and noncompliance in children
with ADHD and ID compared with children with ADHD
and normal IQ.26,28 In contrast, in community samples, the
profiles of comorbidity with emotional and conduct prob-
lems in children with ADHD symptoms did not differ ac-
cording to the presence of mild ID (IQ <70)24 or using
a cutoff of IQ <85.29 A third study found higher rates of non-
compliance, anxiety, depression, and social problems in
those with ADHD and ID compared with those with ID
alone.30
A limitation of previous research is that questionnaires
generally have been used to assess comorbidity rather thanity Disorder 893
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methods used in the present study. Another strength of the
present study is the relatively large sample size of the
ADHD group compared with previous studies. The IQ cut-
point used to delineate comparison groups in the literature
varies, such that in some studies, children with borderline
ID (IQ 70-85) are included in the group of children with
mild ID. Although the present study focused on comparing
children based on an IQ cutpoint of 70, reanalysis of the
data after dividing the children into 3 groups (mild ID: IQ
50-69 [n = 97], borderline ID: IQ 70-84 [n = 380], and typ-
ically developing: IQ $85 [n = 494]) showed a similar pat-
tern of results (Table IV; available at www.jpeds.com).
An important limitation of the present study is that the
presence of ID was defined based primarily on IQ score, be-
cause no measure of adaptive functioning was available. An-
other limitation is that disharmonic IQ profiles were not
considered, and thus children with significant performance
IQ and verbal IQ discrepancies might not necessarily be con-
sidered to have ID in clinical practice. However, given that IQ
alone is often the basis for exclusion criteria in ADHD re-
search, the implications of our findings are valid in this con-
text. Samples are also likely to be heterogeneous because of
ascertainment differences in referred samples. Our sample
comprised referred cases, and thus the higher rate of CD in
our cohort may be related to the fact that these children
were identified with ADHD and referred. Because this sub-
group of children with ADHD + ID are excluded from virtu-
ally all clinical, etiologic, and treatment studies, furtherwork is
needed to verify our findings. A further limitation of this study
is that we were unable to take into account the variable effects
of medication timing and dosage. However, in those children
receiving a stimulantmedication,whether or not they took the
medication on the day of testing had no effect onwhether they
were classified as ADHD + ID or ADHD-only.
A related question that is beyond the scope of the present
study is the extent to which the presence of ID in children
with ADHD indexes a different etiology. Previous work has
shown that children with ADHD + ID are significantly
more likely to have large, rare structural deletions or duplica-
tions of DNA, called copy number variants (CNVs).31 Im-
portantly however, CNVs are also associated with ADHD
without ID.32 In addition, the presence of such CNVs does
not appear to index a distinct pattern of etiologic correlates,
in the form of various prenatal and perinatal risk factors, or
a distinct clinical profile in children with ADHD with and
without ID.33 Thus, whether the etiology and risk correlates
of ADHD are substantially different in affected children
with and without ID remains unclear, and further work is
needed to explore this question.
Our results, together with other findings, suggest that ex-
cluding children with ADHD from services and interventions
on the basis of the presence of mild ID is clinically unwar-
ranted, given that children with ADHD and ID do not
seem to differ from those without ID in terms of ADHD sub-
type and number of ADHD symptoms. They are more likely
to have CD, however. It also appears that they differ from894children with ID alone, suggesting that ID does not drive
the link to conduct problems. Thus, services that deal with
ADHD should be well placed to manage ADHD in children
with mild ID; however, they will need access to the types of
social and clinical interventions that will also help manage as-
sociated conduct problems. n
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Table III. Clinical features of children with ADHD + ID (clinical sample) and those with ID only (ALSPAC sample) after
matching the samples based on IQ
Variables
ADHD + ID (n = 58) ID-only (n = 58) Statistics
n (%) Mean (SD) n (%) Mean (SD) OR 95% CI P
Age, years 10.6 (2.9) 10.8 (0.1) 0.96 0.80-1.15 .64
Male sex 50 (86.2) 31 (53.4) 0.18 0.07-0.46 2.5E-04
ODD symptom count 4.1 (2.3) 0.2 (0.7) 5.08 2.63-9.79 1.2E-06*
CD symptom count (out of 7) 1.1 (1.5) 0.0 (0.3) 11.41 2.82-46.13 6.4E-04*
ODD diagnosis 28 (48.3) 2 (3.4) 32.09 6.26-164.56 3.2E-05*
CD diagnosis 16 (16.7) 0 (0.0) NA NA NA†
*A adjusted for the covariates: child’s age at time of assessment, sex, and IQ.
†Because there were no CD diagnoses in the ID-only group, statistical calculation was not applicable.
Table IV. Clinical features of children with ADHD + ID compared with those with IQ 70-84 and those with IQ $85
Variables




with ADHD + ID)




with ADHD + ID)
n (%) Mean (SD) OR 95% CI P† n (%) Mean (SD) OR 95% CI P†
Age, years 10.2 (2.8) 0.87 0.80-0.94 .0004 9.8 (2.7) 0.82 0.76-0.88 4.5E07
Male sex 317 (83.4) 1.28 0.68-2.44 .45 422 (85.4) 1.10 0.58-2.08 .76
DSM-IV Combined ADHD diagnosis 277 (73.5) 0.54 0.30-0.96 .04 354 (72.0) 0.49 0.28-0.87 .01
DSM-IV Inattentive ADHD diagnosis 21 (5.5) 1.44 0.52-3.99 .49 30 (6.1) 1.79 0.66-4.87 .25
DSM-IV Hyperactive-Impulsive ADHD diagnosis 41 (10.8) 1.86 0.76-4.54 .17 46 (9.3) 1.55 0.63-3.76 .34
DSM-III-R ADHD diagnosis only 34 (9.0) 1.78 0.67-4.69 .25 55 (11.2) 2.23 0.86-5.77 .10
DSM-IV ODD diagnosis 160 (42.6) 1.19 0.75-1.90 .45 239 (48.8) 1.51 0.95-2.37 .08
DSM-IV CD diagnosis 82 (21.6) 0.55 0.34-0.89 .02 54 (10.9) 0.25 0.15-0.41 7.8E08
ADHD symptoms: inattentive 7.3 (1.7) 0.79 0.46-1.36 .40z 7.3 (1.7) 0.80 0.47-1.36 .41z
ADHD symptoms: hyperactive-impulsive 7.8 (1.3) 0.81 0.45-1.45 .48z 7.7 (1.6) 0.66 0.37-1.18 .16z
ADHD symptoms: total 15.2 (2.4) 0.94 0.85-1.04 .21 15.1 (2.4) 0.92 0.83-1.01 .09
DSM-IV ODD symptom count 3.9 (2.4) 0.95 0.86-1.05 .33 3.7 (2.3) 0.89 0.81-0.99 .02
DSM-IV CD symptom count 1.3 (1.76) 0.53 0.37-0.75 .0003z 0.9 (1.3) 0.34 0.24-0.48 1.5E09z
DSM-IV anxiety symptoms 1.1 (1.9) 0.84 0.58-1.20 .33z 1.1 (2.0) 0.82 0.57-1.18 .29z
DSM-IV depression symptoms 1.2 (1.4) 0.72 0.47-1.11 .13z 1.3 (1.3) 0.86 0.57-1.31 .49z
*All clinical analyses are adjusted for the covariate child’s age.
†Critical P value corrected for multiple testing: P < .003.
zTransformed.
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